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Snake venoms comprise a complex mixture of macromolecules, primarily 
proteins, that can cause cataclysmic destructive changes to living tissues when 
injected by a snake. Somewhat enigmatically, these same molecules have high 
potential for medicinal purposes, because most venom components are mimics 
of natural regulators of body functions. Previous studies have revealed that 
serine proteases in venoms interact with the blood coagulation cascade, a 
complex series of protease-mediated reactions in the body which regulate and 
the thrombin-like serine proteases (TLSP) act preferentially on fibrinogen. The 
isolation and manipulation of these proteins could directly contribute to the 
treatment of clotting disorders, acute hypertension, and even some cancers. New 
drug candidates are necessary because current drugs have undesired side effects 
and several newer candidates have recently failed in clinical trials. To address 
this need, I am examining TLSPs from the venom of the Yucatan Rattlesnake 
(Crotalus simus tzabcan), a species whose venom has not been investigated but 
which contains abundant serine proteases. Isolation of a TLSP has just been 
completed using a three step chromatographic purification protocol (low 
pressure size exclusion, ion exchange and reversed phase). Initial 
characterization of this purified protein include determination of its mass, 
specific activity and possible inhibitors. In addition, I will evaluate other physical 
characteristics of the protein such as extent of glycosylation, which can influence 
physiological stability and resistance to endogenous proteases, and specific 
activity toward fibrinogen and other natural substrates. Identification of these 
properties are the first steps toward a future therapeutic, and if these are 
positive, biological testing in a rodent model will be undertaken. This research 
further demonstrates the potential for new and more specific-acting drugs from 
natural sources, and animal venoms contain a wealth of candidate molecules 
potentially useful for treating human diseases. 	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